UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease

Frontiers in oncology, 2020-02, Vol.10, p.172-172

2020

Link zum Volltext

Verfügbarkeit prüfen

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

The Prostate, 2015-09, Vol.75 (12), p.1227-1246

2015

Link zum Volltext

Verfügbarkeit prüfen

Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study

Journal of cancer research and clinical oncology, 2020-05, Vol.146 (5), p.1273-1290

2020

Link zum Volltext

Verfügbarkeit prüfen

Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice

BMC cancer, 2019-10, Vol.19 (1), p.960-960, Article 960

2019

Link zum Volltext

Verfügbarkeit prüfen

Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy

Frontiers in oncology, 2020-08, Vol.10

2020

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A

International journal of molecular sciences, 2020-11, Vol.21 (21), p.8222

2020

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review

Diagnostics (Basel), 2024-02, Vol.14 (4), p.424

2024

Link zum Volltext

Verfügbarkeit prüfen

Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications

PloS one, 2015-06, Vol.10 (6), p.e0129762-e0129762

2015

Link zum Volltext

Verfügbarkeit prüfen

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Journal of translational medicine, 2019-08, Vol.17 (1), p.296-296, Article 296

2019

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples

International journal of oncology, 2013-06, Vol.42 (6), p.2116-2122

2013

Link zum Volltext

Verfügbarkeit prüfen

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines

International journal of oncology, 2014-01, Vol.44 (1), p.285-294

2014

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

Endocrine-related cancer, 2009-06, Vol.16 (2), p.401-413

2009

Link zum Volltext

Verfügbarkeit prüfen

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers

Therapeutic advances in medical oncology, 2019, Vol.11, p.1758835919846421-1758835919846421

2019

Link zum Volltext

Verfügbarkeit prüfen

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

BMC cancer, 2010-10, Vol.10 (1), p.567-567, Article 567

2010

Link zum Volltext

Verfügbarkeit prüfen

Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models

Anti-cancer agents in medicinal chemistry, 2014-01, Vol.14 (7), p.1031

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

BMC medicine, 2012-11, Vol.10 (1), p.135-135, Article 135

2012

Link zum Volltext

Verfügbarkeit prüfen

Home Care for Cancer Patients After an Earthquake: The Experience of the “L’Aquila per la Vita” Home Care Unit

Journal of pain and symptom management, 2011-09, Vol.42 (3), p.e1-e4

2011

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

The Lancet (British edition), 2020-12, Vol.396 (10265), p.1817-1828

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive italian breast and/or ovarian cancer families

Breast cancer research and treatment, 2007-12, Vol.106 (2), p.289-296

2007

Link zum Volltext

Verfügbarkeit prüfen

Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy

Expert opinion on biological therapy, 2011-06, Vol.11 (6), p.821-824

2011

Link zum Volltext

Verfügbarkeit prüfen

Changes of Topoisomerase IIα Expression in Breast Tumors after Neoadjuvant Chemotherapy Predicts Relapse-Free Survival

Clinical cancer research, 2006-03, Vol.12 (5), p.1501-1506

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments

Pharmacogenomics and personalized medicine, 2020-01, Vol.13, p.601-617

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(139)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(87)
Humans
(76)
Oncology
(62)
Female
(47)
Male
(42)
Middle Aged
(31)
Aged
(29)
Tumors
(26)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Adult
(22)
Chemotherapy
(22)
Metastasis
(20)
Mutation
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Colorectal Cancer
(17)
Treatment Outcome
(17)
Breast Cancer
(16)
Cancer
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
International Journal Of Oncology
(9)
Oncotarget
(8)
The Prostate
(7)
Annals Of Oncology
(6)
Bmc Medicine
(5)
Breast Cancer Research And Treatment
(4)
Supportive Care In Cancer
(4)
Tumori
(4)
Bmc Cancer
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study

Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases

Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A

Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review

Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

Home Care for Cancer Patients After an Earthquake: The Experience of the “L’Aquila per la Vita” Home Care Unit

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive italian breast and/or ovarian cancer families

Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy

Changes of Topoisomerase IIα Expression in Breast Tumors after Neoadjuvant Chemotherapy Predicts Relapse-Free Survival

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments

Suchergebnisse filtern